Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Respiratory Distress Syndrome
50%
Alveolar Capillary
25%
Anti-inflammatory Activity
25%
Beneficial Effects
25%
Capillary Fluids
25%
Clinical Effect
25%
Clinical Efficacy
25%
Clinical Experience
25%
Compassionate Use
25%
Epithelial Apoptosis
25%
Fluid Leakage
25%
Hemodynamic Failure
25%
Immunomodulatory
25%
Immunomodulatory Properties
25%
In Vitro Anti-inflammatory Activity
25%
In Vitro Study
25%
In Vivo Effects
100%
In Vivo Efficacy
50%
In Vivo Inflammation
25%
Inflammation Markers
25%
Inflammatory Cytokines
25%
Inflammatory Diseases
25%
Lung Protection
25%
Mechanistic Information
25%
Mesenchymal Stromal Cells
100%
MicroRNA
25%
Monocytes
25%
Multiple Organ Failure
25%
Neutrophils
25%
Potency Assessment
50%
Proinflammatory Chemokines
25%
Proteomic Profile
25%
Randomized Clinical Trial
25%
Regulatory Phenotype
25%
Respiratory Failure
25%
Severe Acute Respiratory Distress Syndrome
100%
Systemic Infusion
25%
Systemic Markers
25%
T Cell Response
25%
T Cells
25%
Medicine and Dentistry
Acute Respiratory Distress Syndrome
100%
Antiinflammatory Activity
25%
Capillary
25%
Chemokine
25%
Compassionate Use
25%
Cytokine
25%
Hemodynamic
25%
In Vitro
75%
Inflammation
50%
Inflammatory Disorder
25%
Infusion
25%
Lung
25%
Mesenchymal Stem Cell
100%
microRNA
25%
Monocyte
25%
Multiple Organ Dysfunction Syndrome
25%
Neutrophil
25%
Programmed Cell Death
25%
Proteomics
25%
Randomized Clinical Trials
25%
Respiratory Failure
25%
T Cell
25%
T-Cell Response
25%
Neuroscience
Anti-Inflammatory
25%
Chemokine
25%
Distress Syndrome
100%
In Vitro
75%
In Vivo
100%
Mesenchymal Stem Cell
100%
MicroRNA
25%
Monocyte
25%
Programmed Cell Death
25%
Proinflammatory Cytokine
25%
Proteomics
25%
T Cell
50%
Immunology and Microbiology
Antiinflammatory Activity
25%
Capillary
25%
Chemokine
25%
Hemodynamic
25%
In Vitro
75%
Inflammation
50%
Inflammatory Disorder
25%
Lung
25%
Mesenchymal Stem Cell
100%
Monocyte
25%
Neutrophil
25%
Programmed Cell Death
25%
Proinflammatory Cytokine
25%
Proteomics
25%
T Cell
50%
Veterinary Science and Veterinary Medicine
Diseases
25%
Hemodynamic
25%
In Vitro
75%
Inflammation
50%
Lung
25%
Mesenchymal Stem Cell
100%
MicroRNA
25%
Monocyte
25%
Proteomics
25%
T Cell
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
100%
Anti-Inflammatory Drug
33%
Chemokine
33%
Cytokine
33%
Inflammation
66%
Inflammatory Disease
33%
microRNA
33%
Multiple Organ Failure
33%
Randomized Clinical Trial
33%